Authors

Julia ML Brotherton

B Med (Hons), MPH (Hons), GradDipAppEpi, FAFPHM, PhD, GAICD, Medical Director, Registries and Research, Victorian Cytology Service; Honorary Principal Fellow, School of Population and Global Health, University of Melbourne, Vic. jbrother@vcs.org.au

Human papillomavirus vaccination update: Nonavalent vaccine and the two-dose schedule

The aim of this article is to provide an overview of the nonavalent HPV vaccine, the rationale for its use, and the updated dose scheduling requirements for HPV vaccine.